Join STAT reporters along with selected experts in the field to discuss their perspectives on this question. STAT Plus subscribers enjoy free access for themselves.

Panels include:

• How gene therapy took on cancer: Steve Rosenberg pioneered genetically editing white blood cells to kill tumors. He’ll chart this treatment’s long path to market — and offer us a look ahead.

• When business and science collide: New gene therapies have immense benefits, but they come at high one-time costs. Here, leaders from the pharmaceutical and insurance industries and the public sector will discuss how to get these breakthroughs to the patients who need them.